BioCryst Pharmaceuticals, Inc. (BMV:BCRX)

BioCryst Pharmaceuticals Revenue

BioCryst Pharmaceuticals had revenue of $159.40M USD in the quarter ending September 30, 2025, with 36.14% growth. This brings the company's revenue in the last twelve months to $599.82M, up 45.38% year-over-year. In the year 2024, BioCryst Pharmaceuticals had annual revenue of $450.71M with 36.00% growth.

• Revenue (ttm): $599.82M
• Revenue Growth: +45.38%
• P/S Ratio: 2.64
• Revenue / Employee: $1.03M
• Employees: 580
• Market Cap: 29.07B MXN

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	450.71M	119.30M	36.00%
Dec 31, 2023	331.41M	60.59M	22.37%
Dec 31, 2022	270.83M	113.66M	72.31%
Dec 31, 2021	157.17M	139.36M	782.38%
Dec 31, 2020	17.81M	-31.02M	-63.53%